ステロイドに対する応答性を調節する方法

Japanese Patent JP5886699

B2

The present invention makes it possible to enhance steroid efficacy in a steroid refractory patient afflicted with an inflammatory condition not responding or responding poorly or inadequately to anti-inflammatory treatment, by administering an effective to said patient amount of an oligonucleotide comprising the sequence TTCGT and having a total length of up to 100 nucleotides. The invention also encompasses the use of said oligonucleotide for the manufacture of pharmaceuticals.

JP2008525008	Vaccine against Neisseria meningitidis
WO/1993/022434	TARGETED CLEAVAGE OF RNA USING EUKARYOTIC RIBONUCLEASE P AND EXTERNAL GUIDE SEQUENCE
JP2016526915	A mini circle DNA recombination parent plasmid which has the antibody gene revelation cassette genetically engineered, Mini circle DNA and use [reference of related application] this application which have the revelation cassette, A title of an invention "a mini circle DNA recombination parent plasmid which has the antibody gene revelation cassette genetically engineered, A right of priority of the China patent application 201310339305. No. 0 for which it applied on August 06, 2013 considered as mini circle DNA and use which have the revelation cassette" is claimed, and all those contents are included in this specification as reference.

Anne-Kristin Speak
Robert Lefberg
Lisa Charlotte Bandholtz
Oliver von Stain
Arezou Zargari

JP2012149039A

March 16, 2016

July 03, 2012

Click for automatic bibliography generation  

Index Pharmaceuticals Actie Borag

A61K31/7088; A61K31/57; A61K31/712; A61K31/7125; A61P1/04; A61P11/00; A61P11/06; A61P17/06; A61P19/02; A61P29/00; C12N15/117

JP5208734B2
JP2012232988A
JP2008535859A
JP2008544984A

Junji Yuda
Noriyuki Takebayashi

Previous Patent: モノクロ表示用液晶表示装置

Next Patent: JPS5886700